Summary
Boston Scientific Corporation (BSX) filed an 8-K on July 22, 2003, to report on their second quarter financial results for the period ended June 30, 2003. This filing primarily served to furnish a press release announcing these results, as required by Regulation FD. Investors should note that the information provided in this report and the attached press release is furnished and not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. The core of this announcement is the financial performance for the second quarter of 2003. While the 8-K itself does not detail the financial figures, it directs investors to the accompanying press release for specific revenue, earnings, and other key financial metrics. This is a standard practice for companies to disseminate material financial information to the public simultaneously.
Key Highlights
- 1Boston Scientific Corporation (BSX) filed an 8-K report on July 22, 2003.
- 2The filing's primary purpose was to announce the company's financial results for the second quarter ended June 30, 2003.
- 3A press release detailing these financial results was furnished as an exhibit to the 8-K.
- 4The announcement was made in accordance with Regulation FD disclosure requirements.
- 5The information furnished in this report is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
- 6The report directs investors to the attached press release for specific financial performance details.